Prosecution Insights
Last updated: April 19, 2026

Gritstone Bio Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
1
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18300747 ANTIGEN-BINDING PROTEINS AND RELATED METHODS OF USE PUTTLITZ, KARL J 1646 Non-Final OA Apr 14, 2023
18048407 CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF LEE, HOI YAN NMN 1693 Non-Final OA Oct 20, 2022
17820434 ANTIGEN-BINDING PROTEINS TARGETING KKLC-1 SHARED ANTIGEN BELYAVSKYI, MICHAIL A 1644 Non-Final OA Aug 17, 2022
17838114 DURABLE VACCINATION CHEN, STACY BROWN 1672 Non-Final OA Jun 10, 2022
17736738 SHARED NEOANTIGEN VACCINES HILL, KEVIN KAI 1638 Non-Final OA May 04, 2022
17269246 ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS SWARTWOUT, BRIANNA KENDALL 1644 Final Rejection Feb 17, 2021
16975823 Neoantigen Identification with Pan-Allele Models BAILEY, STEVEN WILLIAM 1687 Non-Final OA Aug 26, 2020

Managing Gritstone Bio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month